Trial Profile
Safety, tolerability, pharmacokinetics and pharmacodynamics of Pradigastat in obese but otherwise healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2017
Price :
$35
*
At a glance
- Drugs Pradigastat (Primary)
- Indications Hyperlipoproteinaemia type I
- Focus First in man; Pharmacodynamics
- 30 Nov 2017 New trial record